Kristina Masson

1.1k total citations
14 papers, 693 citations indexed

About

Kristina Masson is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Kristina Masson has authored 14 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Hematology. Recurrent topics in Kristina Masson's work include Acute Myeloid Leukemia Research (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Kristina Masson is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Kristina Masson collaborates with scholars based in Sweden, United States and Germany. Kristina Masson's co-authors include Lars Rönnstrand, Elke H. Heiß, Hamid Band, Stuart L. Schreiber, Whitney Silkworth, Andrew M. Stern, Christina Scherer, Nathan T. Ross, Jianmin Sun and Michelle Palmer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Kristina Masson

14 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Masson Sweden 12 386 293 118 103 98 14 693
Leslie Giampa United States 11 346 0.9× 256 0.9× 75 0.6× 192 1.9× 55 0.6× 13 783
Guobao Zhang United States 9 305 0.8× 197 0.7× 124 1.1× 27 0.3× 154 1.6× 15 594
Elisabeth A. Lasater United States 12 522 1.4× 559 1.9× 222 1.9× 92 0.9× 37 0.4× 21 963
Rosalind H. Gunby Italy 13 316 0.8× 267 0.9× 222 1.9× 57 0.6× 42 0.4× 17 683
Richard Smykla United States 11 202 0.5× 224 0.8× 165 1.4× 68 0.7× 59 0.6× 16 637
Sujata Chakraborty United States 10 286 0.7× 272 0.9× 146 1.2× 40 0.4× 22 0.2× 17 541
Ryan P. Million United States 11 340 0.9× 503 1.7× 298 2.5× 155 1.5× 46 0.5× 15 944
Mika Kontro Finland 13 505 1.3× 423 1.4× 189 1.6× 77 0.7× 43 0.4× 53 903
Koshi Akahane Japan 14 301 0.8× 181 0.6× 94 0.8× 99 1.0× 38 0.4× 63 658
Corynn Kasap United States 6 253 0.7× 214 0.7× 151 1.3× 20 0.2× 61 0.6× 12 490

Countries citing papers authored by Kristina Masson

Since Specialization
Citations

This map shows the geographic impact of Kristina Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Masson more than expected).

Fields of papers citing papers by Kristina Masson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Masson. The network helps show where Kristina Masson may publish in the future.

Co-authorship network of co-authors of Kristina Masson

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Masson. A scholar is included among the top collaborators of Kristina Masson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Masson. Kristina Masson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Emdal, Kristina B., Nicolàs Palacio‐Escat, Caroline Wigerup, et al.. (2022). Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance. Cell Reports. 40(6). 111177–111177. 21 indexed citations
2.
Hass, Helge, Kristina Masson, Violette Paragas, et al.. (2017). Predicting ligand-dependent tumors from multi-dimensional signaling features. npj Systems Biology and Applications. 3(1). 27–27. 31 indexed citations
3.
Abu‐Yousif, Adnan O., Jessica B. Casaletto, Kristina Masson, et al.. (2015). Abstract 1690: Mechanistic characterization of MM-131, a bispecific antibody that blocks c-Met signaling through concurrent targeting of EpCAM. Cancer Research. 75(15_Supplement). 1690–1690. 2 indexed citations
4.
Spoonamore, James, Michel Weïwer, Kristina Masson, et al.. (2014). Screen for Inhibitors of STK33 Kinase Activity. Fordham law review. 77(6). 3163–205. 2 indexed citations
5.
Weïwer, Michel, James Spoonamore, Jingqiang Wei, et al.. (2012). A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells. ACS Medicinal Chemistry Letters. 3(12). 1034–1038. 115 indexed citations
6.
Luo, Tuoping, Kristina Masson, Jacob D. Jaffe, et al.. (2012). STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability. Proceedings of the National Academy of Sciences. 109(8). 2860–2865. 65 indexed citations
7.
Kharazi, Shabnam, Adam J. Mead, Anna Mansour, et al.. (2011). Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD–induced myeloproliferation. Blood. 118(13). 3613–3621. 22 indexed citations
8.
Arora, Deepika, Sylvia‐Annette Böhmer, Rinesh Godfrey, et al.. (2011). Protein-tyrosine Phosphatase DEP-1 Controls Receptor Tyrosine Kinase FLT3 Signaling. Journal of Biological Chemistry. 286(13). 10918–10929. 55 indexed citations
9.
Masson, Kristina, et al.. (2009). Oncogenic Flt3 receptors display different specificity and kinetics of autophosphorylation. Experimental Hematology. 37(8). 979–989. 33 indexed citations
10.
Masson, Kristina & Lars Rönnstrand. (2009). Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cellular Signalling. 21(12). 1717–1726. 95 indexed citations
11.
Masson, Kristina, et al.. (2009). A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival. British Journal of Haematology. 146(2). 193–202. 24 indexed citations
12.
Breitenbuecher, Frank, Boyka Markova, Stefan Kasper, et al.. (2009). A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML. Blood. 113(17). 4063–4073. 98 indexed citations
13.
Masson, Kristina, Elke H. Heiß, Hamid Band, & Lars Rönnstrand. (2006). Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation. Biochemical Journal. 399(1). 59–67. 75 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie Giampa Breakdown of academic impact, for papers by Guobao Zhang Breakdown of academic impact, for papers by Elisabeth A. Lasater Breakdown of academic impact, for papers by Rosalind H. Gunby Breakdown of academic impact, for papers by Richard Smykla Breakdown of academic impact, for papers by Sujata Chakraborty Breakdown of academic impact, for papers by Ryan P. Million Breakdown of academic impact, for papers by Mika Kontro Breakdown of academic impact, for papers by Koshi Akahane Breakdown of academic impact, for papers by Corynn Kasap
Rankless by CCL
2026